Arrow Financial’s State Street SPDR S&P Pharmaceuticals ETF XPH Stock Holding History

Arrow Financial’s Portfolio XPH Stock Details XPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-50	Closed	-$2.22K	–	327
2024 Q3	$2.22K	Hold	50	–	–	﹤0.01%	323
2024 Q2	$1.99K	Hold	50	–	–	﹤0.01%	322
2024 Q1	$2.16K	Hold	50	–	–	﹤0.01%	316
2023 Q4	$2.08K	Hold	50	–	–	﹤0.01%	331
2023 Q3	$1.99K	Hold	50	–	–	﹤0.01%	330
2023 Q2	$2.05K	Buy	+50	New	+$2.06K	﹤0.01%	311

Other funds holding XPH

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

KWM

Kingsview Wealth Management Grants Pass, Oregon $8.25B AUM 24.8% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

FCBT

First Citizens Bank & Trust Raleigh, North Carolina $6.69B AUM 24.48% 1-Year Est. Return

Envestnet Portfolio Solutions Chicago, Illinois $20.9B AUM 19.34% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Arrow Financial's XPH Position: Q4 2024 in Review

Arrow Financial sold out of State Street SPDR S&P Pharmaceuticals ETF (XPH) in Q4 2024, closing a stake of 50 shares — an estimated $2.22K sold.

Arrow Financial first reported a position in XPH in Q2 2023 and held it in 6 quarters. The position peaked at $2.22K in Q3 2024. 73 funds tracked by Wall St. Rank hold XPH as of Q4 2024.

Arrow Financial reported no remaining State Street SPDR S&P Pharmaceuticals ETF position as of Q4 2024 after selling out during the quarter.
Arrow Financial sold 50 State Street SPDR S&P Pharmaceuticals ETF shares in Q4 2024, an estimated $2.22K.
Arrow Financial first reported a position in State Street SPDR S&P Pharmaceuticals ETF in Q2 2023 and held it in 6 quarters.
Arrow Financial's State Street SPDR S&P Pharmaceuticals ETF position peaked at $2.22K in Q3 2024.
73 funds tracked by Wall St. Rank held State Street SPDR S&P Pharmaceuticals ETF as of Q4 2024.

Based on Arrow Financial's 13F filing for Q4 2024, filed 14 Feb 2025.